Skip to main content
. 2022 Apr 6;11(7):1238. doi: 10.3390/cells11071238

Table 4.

Molecular markers—malignant bone tumors.

Tumor Type Genes/Molecular Profiles Characteristically Altered Diagnostic Marker
Osteosarcoma TP53
RB1
8q21-24 (amplification)
MDM2 (amplification)
extensive and comprehensive
chromosomal rearrangements
+
Ewing sarcoma t(11;22)(q24;q12)
EWSR1-FLI1
t(21;22)(q12;q12)
EWSR1-ERG
t(2;22)(q33;q12)
EWSR1-CREB1
t(7;22)(p22;q12)
EWSR1-ETV1
t(17;22)(q12;q12)
EWSR1-E1AF
inv(22)(q12;q12)
EWSR1-ZSG
t(16;21)(p11;q22)
FUS-ERG
and others
+
Chondrosarcoma HEY1-NCOA2
t(1;5)(q42;q32)
RF2BP2-CDX1
IDH1
IDH2
TP53
+
Giant cell tumor of soft tissue H3F3A
HRAS
TP53
+